Clinical Trials in San Diego

Showing 10401-10420 of 14,679 trials

Extension Study of Gelesis100 on Body Weight

NCT03021291

This study is designed to assess the effect of Gelesis100 on body weight after an additional exposure of 24 weeks in subjects who completed the 24-week treatment period, and had at least 3% weight loss, in the Gelesis Loss Of Weight GLOW, NCT02307279) study.

Overweight and Obesity

Gelesis, Inc.36 participantsStarted Jan 2017

San Diego, California, United States • Tustin, California, United States • Aurora, Colorado, United States +13 more locations

COMPLETEDPhase 3< 1 mile

Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine

NCT02357901

This is a randomized, double-blind, placebo controlled, multicenter study in male and female participants who are seeking treatment for opioid use disorder.

Opioid DependenceOpioid Related Disorders

Indivior Inc.665 participantsStarted Jan 2015

Haleyville, Alabama, United States • Hamilton, Alabama, United States • Little Rock, Arkansas, United States +35 more locations

Extension Study of Gelesis100 on Body Weight

Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine

Find Trials by Condition in San Diego

Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes

Telehealth Outreach for Chronic Back Pain

Study HZA106827: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics

A Study of The Impact of Severe Hepatic Impairment on the Pharmacokinetics and Safety of Vemurafenib in BRAF V600 Mutation-Positive Cancer Participants

Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil

Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis

Fluticasone Furoate/GW642444 Inhalation Powder Long-Term Safety Study

SISTERS: Spasticity In Stroke Study - Randomized Study

Safety and Efficacy of INCB013739 Plus Metformin Compared to Metformin Alone on Glycemic Control in Type 2 Diabetics

Study Evaluating the 24-Hour Pulmonary Function Profile of Fluticasone Furoate (FF) /GW642444 (Vilanterol) (VI) Inhalation Powder 100/25mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

VALTREX Once Daily For Viral Shedding In Herpes Simplex Virus 2 (HSV-2) Seropositive Subjects. VALTREX® Tablet is a Trademark of GlaxoSmithKline Group of Companies.

Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy

Safety and Efficacy Study of a New Antiviral Drug to Prevent Cytomegalovirus Reactivation in Bone Marrow Transplanted Patients

Study of Ruxolitinib in Colorectal Cancer Patients

Evaluation of N1539 Following Abdominoplasty Surgery

Evaluation of Primary Plating in Sternotomy Patients for Osteosynthesis and Pain

Phase 2a Study to Evaluate the Efficacy and Safety of MEDI9929 in Adults With Atopic Dermatitis